Sagger Mawri, MD
Interventional Cardiology · Dayton, OHNPI 1750725487
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,853 of the $5,890 with a category attached, or 65.4%. 19 manufacturers reported payments, led by Boston Scientific at 39.9% of the total. Reporting peaked in 2019 at $2,220 and has fallen 71.7% since, to $628 in 2025.
Across 60 payments — averaging $98.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Medtronic$1K
- Abiomed$446
- Shockwave Medical, Inc$405
- Angiodynamics, Inc.$249
- Philips North America LLC$238
- plus $946 from 13 others
Across 3 payments — averaging $8626.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$26K
What the payments were for
- Travel & lodging$2,03735%
- Food & beverage$3,85365%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $2,353 |
| Medtronic | 8 | $1,254 |
| Abiomed | 4 | $446 |
| Shockwave Medical, Inc | 4 | $405 |
| Angiodynamics, Inc. | 4 | $249 |
| Philips North America LLC | 7 | $238 |
| ZOLL Circulation Inc | 1 | $199 |
| W. L. Gore & Associates, Inc. | 1 | $140 |
| Abbott | 4 | $128 |
| Boehringer Ingelheim | 1 | $124 |
| Penumbra, Inc. | 1 | $84 |
| Cardiva Medical, Inc. | 1 | $80 |
| Avinger Inc. | 1 | $68 |
| Janssen Scientific Affairs, LLC | 1 | $46 |
| Amarin Pharma, Inc. | 1 | $17 |
| Veryan Medical Incorporated | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $14 |
| Novartis | 1 | $14 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CROSSBOSS$1,822
- VenaSeal$1,015
- Impella$393
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$252
- TherOx DS2 Console$199
- Catheter$199
- Downstream Cartridge$199
- Auryon Laser System 100-120 Vac$154
- GENERAL VASCULAR INTERVENTION$149
- GORE VIABAHN VBX Balloon Expandable Endo$140
- JARDIANCE$124
- Vascular Lithotripsy$120
- AVVIGO Guidance System$117
How this compares
$5,890 in reported general payments places this provider in the 55th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 40 | $44,185 |
| Repatha SureclickEvolocumab | 25 | $28,872 |
| XareltoRivaroxaban | 14 | $18,035 |
| Ranolazine ErRanolazine | 39 | $2,692 |
| Cilostazol | 162 | $1,736 |
| Metoprolol Succinate | 186 | $1,520 |
| Atorvastatin Calcium | 161 | $1,478 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 115 | $1,157 |
| Nifedipine ErNifedipine | 33 | $1,132 |
| Metoprolol Tartrate | 96 | $905 |
| ClopidogrelClopidogrel Bisulfate | 94 | $839 |
| Bumetanide | 11 | $838 |
| Losartan Potassium | 114 | $776 |
| Spironolactone | 87 | $636 |
| Potassium Chloride | 41 | $482 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Dayton
- Palaniappan MuthappanDayton$36K
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.